Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Multiple Myeloma × Disulfiram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Multiple Myeloma 1

Interventions

Dexamethasone 113 Lenalidomide 62 Bortezomib 61 Cyclophosphamide 60 Calcium Dobesilate 43 fludarabine 38 pomalidomide 35 daratumumab 34 carfilzomib 29 Melphalan 25 fludarabine phosphate 24 dexamethasone acetate 18 dexamethasone 21-phosphate 18 auricularum 16 Filgrastim 16 Whole-Body Irradiation 14 Biopsy 13 Magnetic Resonance Spectroscopy 12 isatuximab 11 Vorinostat 11 Specimen Handling 11 Peripheral Blood Stem Cell Transplantation 11 Tacrolimus 10 Granulocyte Colony-Stimulating Factor 10 venetoclax 9 ixazomib 9 belantamab mafodotin 9 Sirolimus 9 Cyclosporine 9 Rituximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04521335 2023-03-13

Repurpose-1

University of Utah

Phase 1 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡